Nama Chemicals trims losses to SAR 29.3M in 9M 2024; Q3 at SAR 48.1M

11/11/2024 Argaam Exclusive

View other reports

Nama Chemicals Co. narrowed its net loss to SAR 29.3 million in the first nine months of 2024 from SAR 95 million a year earlier.

Financials (M)

Item	9m 2023	9m 2024	Change‬
Revenues	344.50	283.03	(17.8 %)
Gross Income	(27.75)	(38.56)	(38.9 %)
Operating Income	(83.49)	(91.29)	(9.3 %)
Net Income	(95.02)	(29.31)	69.2 %
Average Shares	23.52	23.52	-
EPS (Riyals)	(4.04)	(1.25)	69.2 %

The major reason for decrease in net loss is reversal of impairment on plant, machinery and equipment.

The period’s performance was driven by lower cost of sales due to the decrease in sold quantities, higher selling and distribution expenses due to increase in freight cost in spite of lower sales volume and higher general and admin expenses due to increase in SAP licensing fees and audit fee.

There was an increase in finance cost is due to adoption of IFRS 9 for effective interest rate on SIDF loans.

Similarly, the increase in other income is due to amortization of government grant as per IFRS 9.

Current Quarter Comparison (M)

Compared With The

Item	Q3 2023	Q3 2024	Change‬
Revenues	89.31	96.40	7.9 %
Gross Income	(27.26)	(20.85)	23.5 %
Operating Income	(46.11)	(38.19)	17.2 %
Net Income	(49.86)	(48.08)	3.6 %
Average Shares	23.52	23.52	-
EPS (Riyals)	(2.12)	(2.04)	3.6 %

Item	Q2 2024	Q3 2024	Change‬
Revenues	88.55	96.40	8.9 %
Gross Income	(11.29)	(20.85)	(84.6 %)
Operating Income	(27.46)	(38.19)	(39.1 %)
Net Income	52.95	(48.08)	(190.8 %)
Average Shares	23.52	23.52	-
EPS (Riyals)	2.25	(2.04)	(190.8 %)

Meanwhile, the company reported a decrease in product sales quantities, in addition to the decrease in the average selling prices of final products due to global economic conditions and their impact on the decline in demand.

The chemical producer’s net loss shrank to SAR 48.1 million in Q3 2024 from SAR 49.9 million a year ago.

Sequentially, the company turned to losses against a profit of SAR 52.94 million from Q2 2024.

Shareholders’ equity, with no minority interest, reached SAR 200.27 million by the end of 9M 2024, from SAR 290.9 million in the year-earlier period.

Accumulated losses stood at SAR 35.3 million as of Sept. 30, 2024, representing 13.93% of capital.

View more financial results

Financial results (Million)

Period	Revenues	Change	Gross Income	Change	Operating Income	Change
Q1 2015	127.00	(28.9 %)	(6.45)	(253.4 %)	(21.86)	(31.2 %)
Q2 2015	114.62	(25.2 %)	9.06	305.0 %	(9.01)	64.7 %
Q3 2015	110.47	(32.9 %)	(11.99)	(753.8 %)	(28.74)	(36.5 %)
Q4 2015	107.58	(39.9 %)	(15.56)	(3.9 %)	(32.82)	16.1 %
2015	459.67	(31.9 %)	(24.95)	(50.3 %)	(92.90)	9.3 %
Q1 2016	112.90	(11.1 %)	(1.84)	71.5 %	(18.88)	13.6 %
Q2 2016	122.21	6.6 %	(6.61)	(172.9 %)	(25.80)	(186.3 %)
Q3 2016	102.15	(7.5 %)	(8.46)	29.4 %	(25.01)	13.0 %
Q4 2016	115.62	7.5 %	5.02	132.2 %	(44.19)	(34.6 %)
2016	452.87	(1.5 %)	(11.89)	52.3 %	(113.89)	(22.6 %)
Q1 2017	130.15	15.3 %	16.90	1020.1 %	2.38	112.6 %
Q2 2017	160.04	31.0 %	23.48	455.4 %	5.25	120.3 %
Q3 2017	145.64	42.6 %	19.58	331.3 %	3.56	114.2 %
Q4 2017	162.85	40.9 %	31.13	520.7 %	8.98	120.3 %
2017	598.67	32.2 %	91.09	866.0 %	20.16	117.7 %
Q1 2018	181.84	39.7 %	52.41	210.1 %	36.69	1444.9 %
Q2 2018	162.35	1.4 %	47.65	102.9 %	28.80	448.5 %
Q3 2018	137.48	(5.6 %)	19.24	(1.7 %)	4.32	21.4 %
Q4 2018	142.67	(12.4 %)	8.25	(73.5 %)	(11.02)	(222.7 %)
2018	624.34	4.3 %	127.57	40.0 %	58.80	191.6 %
Q1 2019	148.26	(18.5 %)	26.62	(49.2 %)	3.90	(89.4 %)
Q2 2019	134.21	(17.3 %)	18.62	(60.9 %)	2.39	(91.7 %)
Q3 2019	119.48	(13.1 %)	12.49	(35.1 %)	(2.84)	(165.7 %)
Q4 2019	124.00	(13.1 %)	16.21	96.4 %	16.21	247.2 %
2019	525.94	(15.8 %)	73.94	(42.0 %)	22.22	(62.2 %)
Q1 2020	120.02	(19.0 %)	9.57	(64.0 %)	(6.57)	(268.6 %)
Q2 2020	104.54	(22.1 %)	11.49	(38.3 %)	0.89	(62.7 %)
Q3 2020	99.95	(16.3 %)	3.06	(75.5 %)	(11.80)	(315.5 %)
Q4 2020	114.73	(7.5 %)	(2.95)	(118.2 %)	(21.01)	(229.6 %)
2020	439.24	(16.5 %)	21.17	(71.4 %)	(38.48)	(273.2 %)
Q1 2021	162.82	35.7 %	34.00	255.2 %	12.84	295.5 %
Q2 2021	122.83	17.5 %	28.91	151.7 %	9.48	964.6 %
Q3 2021	134.82	34.9 %	23.66	673.8 %	5.17	143.9 %
Q4 2021	133.81	16.6 %	13.10	544.4 %	(11.67)	44.4 %
2021	554.28	26.2 %	99.68	370.8 %	15.81	141.1 %
Q1 2022	172.81	6.1 %	52.04	53.0 %	32.79	155.4 %
Q2 2022	154.89	26.1 %	51.38	77.7 %	30.81	225.1 %
Q3 2022	132.30	(1.9 %)	17.23	(27.2 %)	(1.68)	(132.4 %)
Q4 2022	117.21	(12.4 %)	0.29	(97.8 %)	(18.27)	(56.5 %)
2022	577.21	4.1 %	120.94	21.3 %	43.65	176.1 %
Q1 2023	131.06	(24.2 %)	2.91	(94.4 %)	(15.12)	(146.1 %)
Q2 2023	124.13	(19.9 %)	(3.41)	(106.6 %)	(22.26)	(172.3 %)
Q3 2023	89.31	(32.5 %)	(27.26)	(258.2 %)	(46.11)	(2,649.5 %)
Q4 2023	100.74	(14.1 %)	(14.93)	(5267.1 %)	(39.34)	(115.4 %)
2023	445.25	(22.9 %)	(42.69)	(135.3 %)	(122.83)	(381.4 %)
Q1 2024	98.08	(25.2 %)	(6.42)	(320.7 %)	(25.64)	(69.6 %)
Q2 2024	88.55	(28.7 %)	(11.29)	(231.6 %)	(27.46)	(23.3 %)
Q3 2024	96.40	7.9 %	(20.85)	23.5 %	(38.19)	17.2 %

Period	Revenues	Change	Gross Income	Change	Operating Income	Change
2014	675.39	(9.2 %)	(16.60)	(126.9 %)	(102.40)	(191.2 %)
2015	459.67	(31.9 %)	(24.95)	(50.3 %)	(92.90)	9.3 %
2016	452.87	(1.5 %)	(11.89)	52.3 %	(113.89)	(22.6 %)
2017	598.67	32.2 %	91.09	866.0 %	20.16	117.7 %
2018	624.34	4.3 %	127.57	40.0 %	58.80	191.6 %
2019	525.94	(15.8 %)	73.94	(42.0 %)	22.22	(62.2 %)
2020	439.24	(16.5 %)	21.17	(71.4 %)	(38.48)	(273.2 %)
2021	554.28	26.2 %	99.68	370.8 %	15.81	141.1 %
2022	577.21	4.1 %	120.94	21.3 %	43.65	176.1 %
2023	445.25	(22.9 %)	(42.69)	(135.3 %)	(122.83)	(381.4 %)

Profit Performance (Million)

Period	Net Income	Change	EPS(Riyal)	Extraordinary Income/Expense	Net Profit Before Unusual Items	EPS Before XO Items
Q1 2015	(31.15)	(109.5 %)	(1.32)	-	(31.15)	(1.32)
Q2 2015	6.45	122.7 %	0.27	10.96	(4.51)	(0.19)
Q3 2015	(23.97)	(2.6 %)	(1.02)	5.82	(29.78)	(1.27)
Q4 2015	(25.36)	44.7 %	(1.08)	8.39	(33.76)	(1.44)
2015	(74.51)	33.8 %	(3.17)	25.16	(99.67)	(4.24)
Q1 2016	(21.94)	29.6 %	(0.93)	-	(21.94)	(0.93)
Q2 2016	(31.45)	(587.5 %)	(1.34)	-	(31.45)	(1.34)
Q3 2016	(30.92)	(29.0 %)	(1.31)	-	(30.92)	(1.31)
Q4 2016	(727.12)	(2,766.7 %)	(30.91)	(673.14)	(53.98)	(2.30)
2016	(811.43)	(989.0 %)	(34.50)	(673.14)	(138.29)	(5.88)
Q1 2017	(3.85)	82.5 %	(0.16)	-	(3.85)	(0.16)
Q2 2017	(2.76)	91.2 %	(0.12)	-	(2.76)	(0.12)
Q3 2017	(2.02)	93.5 %	(0.09)	-	(2.02)	(0.09)
Q4 2017	7.11	101.0 %	0.30	-	7.11	0.30
2017	(1.52)	99.8 %	(0.06)	-	(1.52)	(0.06)
Q1 2018	28.16	832.1 %	1.20	-	28.16	1.20
Q2 2018	23.44	950.0 %	1.00	-	23.44	1.00
Q3 2018	0.75	137.0 %	0.03	-	0.75	0.03
Q4 2018	(17.08)	(340.2 %)	(0.73)	-	(17.08)	(0.73)
2018	35.28	2428.4 %	1.50	-	35.28	1.50
Q1 2019	(2.22)	(107.9 %)	(0.09)	-	(2.22)	(0.09)
Q2 2019	(1.03)	(104.4 %)	(0.04)	-	(1.03)	(0.04)
Q3 2019	(6.39)	(953.7 %)	(0.27)	-	(6.39)	(0.27)
Q4 2019	19.73	215.5 %	0.84	-	19.73	0.84
2019	10.09	(71.4 %)	0.43	-	10.09	0.43
Q1 2020	(7.33)	(230.2 %)	(0.31)	-	(7.33)	(0.31)
Q2 2020	(3.34)	(224.3 %)	(0.14)	-	(3.34)	(0.14)
Q3 2020	(9.91)	(54.9 %)	(0.42)	-	(9.91)	(0.42)
Q4 2020	(24.68)	(225.1 %)	(1.05)	-	(24.68)	(1.05)
2020	(45.25)	(548.5 %)	(1.92)	-	(45.25)	(1.92)
Q1 2021	9.97	236.1 %	0.42	-	9.97	0.42
Q2 2021	9.57	386.9 %	0.41	-	9.57	0.41
Q3 2021	4.86	149.1 %	0.21	-	4.86	0.21
Q4 2021	3.28	113.3 %	0.14	21.03	(17.75)	(0.75)
2021	27.69	161.2 %	1.18	21.03	6.66	0.28
Q1 2022	33.41	235.1 %	1.42	2.10	31.31	1.33
Q2 2022	26.67	178.6 %	1.13	-	26.67	1.13
Q3 2022	(5.37)	(210.3 %)	(0.23)	-	(5.37)	(0.23)
Q4 2022	(17.70)	(639.0 %)	(0.75)	0.78	(18.48)	(0.79)
2022	37.02	33.7 %	1.57	2.88	34.13	1.45
Q1 2023	(18.81)	(156.3 %)	(0.80)	-	(18.81)	(0.80)
Q2 2023	(26.35)	(198.8 %)	(1.12)	-	(26.35)	(1.12)
Q3 2023	(49.86)	(829.4 %)	(2.12)	-	(49.86)	(2.12)
Q4 2023	(57.42)	(224.4 %)	(2.44)	-	(57.42)	(2.44)
2023	(152.44)	(511.8 %)	(6.48)	-	(152.44)	(6.48)
Q1 2024	(34.18)	(81.7 %)	(1.45)	-	(34.18)	(1.45)
Q2 2024	52.95	301.0 %	2.25	81.00	(28.05)	(1.19)
Q3 2024	(48.08)	3.6 %	(2.04)	-	(48.08)	(2.04)

Period	Net Income	Change	EPS(Riyal)	Extraordinary Income/Expense	Net Profit Before Unusual Items	EPS Before XO Items
2014	(112.48)	(153.8 %)	(4.78)	-	(112.48)	(4.78)
2015	(74.51)	33.8 %	(3.17)	25.16	(99.67)	(4.24)
2016	(811.43)	(989.0 %)	(34.50)	(673.14)	(138.29)	(5.88)
2017	(1.52)	99.8 %	(0.06)	-	(1.52)	(0.06)
2018	35.28	2428.4 %	1.50	-	35.28	1.50
2019	10.09	(71.4 %)	0.43	-	10.09	0.43
2020	(45.25)	(548.5 %)	(1.92)	-	(45.25)	(1.92)
2021	27.69	161.2 %	1.18	21.03	6.66	0.28
2022	37.02	33.7 %	1.57	2.88	34.13	1.45
2023	(152.44)	(511.8 %)	(6.48)	-	(152.44)	(6.48)

Profitability

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2015	(4.37 %)	24.12 %	(20.64 %)
Q2 2015	(2.36 %)	29.07 %	(17.93 %)
Q3 2015	(4.59 %)	31.04 %	(20.97 %)
Q4 2015	(5.43 %)	37.53 %	(21.58 %)
2015	(5.43 %)	2.81 %	(21.68 %)
Q1 2016	(4.56 %)	38.93 %	(20.20 %)
Q2 2016	(7.94 %)	33.71 %	(25.80 %)
Q3 2016	(7.30 %)	33.90 %	(26.54 %)
Q4 2016	(2.63 %)	29.10 %	(30.54 %)
2016	(2.63 %)	(3.47 %)	(30.54 %)
Q1 2017	1.46 %	30.53 %	(25.57 %)
Q2 2017	7.27 %	30.71 %	(18.02 %)
Q3 2017	11.78 %	27.90 %	(11.35 %)
Q4 2017	15.22 %	27.75 %	(0.25 %)
2017	15.22 %	12.94 %	(0.25 %)
Q1 2018	19.47 %	30.87 %	4.69 %
Q2 2018	23.10 %	35.65 %	8.69 %
Q3 2018	23.34 %	38.81 %	9.23 %
Q4 2018	20.43 %	37.87 %	5.65 %
2018	20.43 %	19.60 %	5.65 %
Q1 2019	17.23 %	34.20 %	0.83 %
Q2 2019	12.93 %	29.20 %	(3.48 %)
Q3 2019	12.11 %	22.42 %	(4.91 %)
Q4 2019	14.06 %	14.57 %	1.92 %
2019	14.06 %	15.05 %	1.92 %
Q1 2020	11.43 %	13.35 %	1.00 %
Q2 2020	10.63 %	13.36 %	0.57 %
Q3 2020	8.99 %	7.20 %	(0.19 %)
Q4 2020	4.82 %	4.96 %	(10.30 %)
2020	4.82 %	4.96 %	(10.30 %)
Q1 2021	9.46 %	8.90 %	(5.80 %)
Q2 2021	12.60 %	8.73 %	(3.01 %)
Q3 2021	15.63 %	9.84 %	(0.05 %)
Q4 2021	17.98 %	14.25 %	1.20 %
2021	17.98 %	14.25 %	1.20 %
Q1 2022	20.86 %	17.67 %	4.96 %
Q2 2022	23.51 %	20.68 %	7.56 %
Q3 2022	22.52 %	23.46 %	5.87 %
Q4 2022	20.95 %	19.59 %	5.91 %
2022	20.95 %	19.59 %	5.91 %
Q1 2023	13.41 %	12.05 %	(2.99 %)
Q2 2023	3.37 %	1.51 %	(13.67 %)
Q3 2023	(5.95 %)	(8.39 %)	(24.58 %)
Q4 2023	(9.59 %)	(13.17 %)	(34.24 %)
2023	(9.59 %)	(13.17 %)	(34.24 %)
Q1 2024	(12.62 %)	(17.39 %)	(40.70 %)
Q2 2024	(15.90 %)	(20.86 %)	(45.00 %)
Q3 2024	(13.94 %)	(17.32 %)	(43.71 %)

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
2014	(2.46 %)	0.30 %	(16.65 %)
2015	(5.43 %)	2.81 %	(21.68 %)
2016	(2.63 %)	(3.47 %)	(30.54 %)
2017	15.22 %	12.94 %	(0.25 %)
2018	20.43 %	19.60 %	5.65 %
2019	14.06 %	15.05 %	1.92 %
2020	4.82 %	4.96 %	(10.30 %)
2021	17.98 %	14.25 %	1.20 %
2022	20.95 %	19.59 %	5.91 %
2023	(9.59 %)	(13.17 %)	(34.24 %)

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2015	(5.08 %)	3.78 %	(24.53 %)
Q2 2015	7.90 %	38.43 %	(3.93 %)
Q3 2015	(10.85 %)	45.89 %	(26.96 %)
Q4 2015	(14.47 %)	67.84 %	(31.38 %)
Q1 2016	(1.63 %)	5.08 %	(19.43 %)
Q2 2016	(5.41 %)	19.09 %	(25.73 %)
Q3 2016	(8.29 %)	47.71 %	(30.27 %)
Q4 2016	4.34 %	46.71 %	(46.69 %)
Q1 2017	12.99 %	13.42 %	(2.96 %)
Q2 2017	14.67 %	22.37 %	(1.72 %)
Q3 2017	13.44 %	31.97 %	(1.39 %)
Q4 2017	19.11 %	40.71 %	4.37 %
Q1 2018	28.82 %	28.66 %	15.49 %
Q2 2018	29.35 %	41.69 %	14.44 %
Q3 2018	14.00 %	46.60 %	0.54 %
Q4 2018	5.79 %	36.83 %	(11.97 %)
Q1 2019	17.96 %	11.96 %	(1.50 %)
Q2 2019	13.87 %	22.30 %	(0.77 %)
Q3 2019	10.45 %	18.31 %	(5.35 %)
Q4 2019	13.07 %	5.70 %	15.91 %
Q1 2020	7.98 %	6.32 %	(6.10 %)
Q2 2020	10.99 %	24.89 %	(3.19 %)
Q3 2020	3.06 %	(8.37 %)	(9.91 %)
Q4 2020	(2.57 %)	(3.02 %)	(21.51 %)
Q1 2021	20.88 %	17.63 %	6.12 %
Q2 2021	23.54 %	21.81 %	7.79 %
Q3 2021	17.55 %	0.46 %	3.61 %
Q4 2021	9.79 %	17.10 %	(13.26 %)
Q1 2022	30.11 %	28.60 %	18.12 %
Q2 2022	33.17 %	32.55 %	17.22 %
Q3 2022	13.02 %	12.55 %	(4.06 %)
Q4 2022	0.25 %	(2.89 %)	(15.77 %)
Q1 2023	2.22 %	0.68 %	(14.35 %)
Q2 2023	(2.74 %)	(5.21 %)	(21.22 %)
Q3 2023	(30.52 %)	(33.33 %)	(55.83 %)
Q4 2023	(14.82 %)	(23.13 %)	(57.00 %)
Q1 2024	(6.55 %)	(10.91 %)	(34.85 %)
Q2 2024	(12.75 %)	(15.08 %)	(31.68 %)
Q3 2024	(21.63 %)	(19.83 %)	(49.87 %)

Per Share Data (Riyal)

Compared With The

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
Q1 2015	23.52	(5.47)	(5.47)	50.54
Q2 2015	23.52	(3.99)	(4.46)	51.46
Q3 2015	23.52	(4.02)	(4.73)	49.19
Q4 2015	23.52	(3.15)	(4.22)	46.61
Q1 2016	23.52	(2.76)	(3.83)	44.08
Q2 2016	23.52	(4.37)	(4.97)	42.99
Q3 2016	23.52	(4.66)	(5.02)	41.79
Q4 2016	23.52	(34.50)	(5.88)	11.83
Q1 2017	23.52	(33.73)	(5.11)	11.94
Q2 2017	23.52	(32.51)	(3.89)	11.69
Q3 2017	23.52	(31.28)	(2.66)	11.91
Q4 2017	23.52	(0.06)	(0.06)	11.66
Q1 2018	23.52	1.30	1.30	14.19
Q2 2018	23.52	2.41	2.41	15.31
Q3 2018	23.52	2.53	2.53	15.04
Q4 2018	23.52	1.50	1.50	14.04
Q1 2019	23.52	0.21	0.21	14.84
Q2 2019	23.52	(0.83)	(0.83)	13.90
Q3 2019	23.52	(1.14)	(1.14)	12.75
Q4 2019	23.52	0.43	0.43	13.41
Q1 2020	23.52	0.21	0.21	11.50
Q2 2020	23.52	0.11	0.11	12.17
Q3 2020	23.52	(0.04)	(0.04)	12.39
Q4 2020	23.52	(1.92)	(1.92)	12.19
Q1 2021	23.52	(1.19)	(1.19)	13.06
Q2 2021	23.52	(0.64)	(0.64)	13.76
Q3 2021	23.52	(0.01)	(0.01)	13.73
Q4 2021	23.52	1.18	0.28	14.87
Q1 2022	23.52	2.17	1.19	15.57
Q2 2022	23.52	2.90	1.92	16.70
Q3 2022	23.52	2.47	1.48	16.47
Q4 2022	23.52	1.57	1.45	16.41
Q1 2023	23.52	(0.65)	(0.68)	15.61
Q2 2023	23.52	(2.90)	(2.93)	14.49
Q3 2023	23.52	(4.79)	(4.83)	12.37
Q4 2023	23.52	(6.48)	(6.48)	9.76
Q1 2024	23.52	(7.13)	(7.13)	8.69
Q2 2024	23.52	(3.76)	(7.21)	10.56
Q3 2024	23.52	(3.69)	(7.13)	8.52

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
2014	23.52	(4.78)	(4.78)	52.18
2015	23.52	(3.17)	(4.24)	46.61
2016	23.52	(34.50)	(5.88)	11.83
2017	23.52	(0.06)	(0.06)	11.66
2018	23.52	1.50	1.50	14.04
2019	23.52	0.43	0.43	13.41
2020	23.52	(1.92)	(1.92)	12.19
2021	23.52	1.18	0.28	14.87
2022	23.52	1.57	1.45	16.41
2023	23.52	(6.48)	(6.48)	9.76

Multiple Ratios (End of Period Price)

Compared With The

Period	P/E	Adjusted P/E	Price/book
Q1 2015	NEG	NEG	1.19
Q2 2015	NEG	NEG	1.15
Q3 2015	NEG	NEG	0.93
Q4 2015	NEG	NEG	0.84
Q1 2016	NEG	NEG	0.72
Q2 2016	NEG	NEG	0.81
Q3 2016	NEG	NEG	0.63
Q4 2016	NEG	NEG	2.87
Q1 2017	NEG	NEG	1.81
Q2 2017	0.00	NEG	1.19
Q3 2017	NEG	NEG	1.79
Q4 2017	NEG	NEG	1.51
Q1 2018	13.59	13.59	1.24
Q2 2018	11.74	11.74	1.85
Q3 2018	10.56	10.56	1.78
Q4 2018	18.10	18.10	1.93
Q1 2019	More than 100	More than 100	1.78
Q2 2019	NEG	NEG	1.59
Q3 2019	NEG	NEG	1.44
Q4 2019	55.08	55.08	1.76
Q1 2020	84.56	84.56	1.56
Q2 2020	More than 100	More than 100	1.52
Q3 2020	NEG	NEG	2.63
Q4 2020	NEG	NEG	2.73
Q1 2021	NEG	NEG	2.77
Q2 2021	NEG	NEG	3.31
Q3 2021	NEG	NEG	3.39
Q4 2021	27.39	More than 100	2.17
Q1 2022	18.84	34.40	2.63
Q2 2022	12.74	19.27	2.21
Q3 2022	17.80	29.61	2.66
Q4 2022	20.97	22.74	2.01
Q1 2023	NEG	NEG	2.09
Q2 2023	NEG	NEG	2.48
Q3 2023	NEG	NEG	2.66
Q4 2023	NEG	NEG	3.29
Q1 2024	NEG	NEG	3.68
Q2 2024	NEG	NEG	2.60
Q3 2024	NEG	NEG	3.29

Period	P/E	Adjusted P/E	Price/book
2014	NEG	NEG	1.12
2015	NEG	NEG	0.84
2016	NEG	NEG	2.87
2017	NEG	NEG	1.51
2018	18.10	18.10	1.93
2019	55.07	55.07	1.76
2020	NEG	NEG	2.73
2021	27.39	More than 100	2.17
2022	20.97	22.74	2.01
2023	NEG	NEG	3.29

Business Segments (Million)

Compared With The

Period	Epoxy Resins Products	Chlor Alkali Products	Others	Consolidation adjustments & eliminations
Q1 2015	98.10	37.91	-	(9.01)
Q2 2015	96.67	40.66	-	(22.71)
Q3 2015	82.51	41.67	-	(13.71)
Q4 2015	65.48	43.09	-	(0.99)
Q1 2016	70.08	41.97	5.18	(4.33)
Q2 2016	78.57	43.70	5.18	(5.24)
Q3 2016	60.58	41.61	5.18	(5.21)
Q4 2016	71.33	42.86	5.18	(3.75)
Q1 2017	79.13	56.07	5.18	(10.23)
Q2 2017	99.62	65.98	5.18	(10.74)
Q3 2017	87.17	58.67	5.18	(5.38)
Q4 2017	88.33	81.34	5.22	(12.04)
Q1 2018	125.21	55.77	5.26	(4.40)
Q2 2018	102.28	62.99	5.23	(8.14)
Q3 2018	82.74	55.34	5.23	(5.83)
Q4 2018	84.69	56.99	5.25	(4.26)
Q1 2019	86.23	61.34	5.21	(4.53)
Q2 2019	73.23	60.25	5.21	(4.48)
Q3 2019	65.05	53.21	5.23	(4.02)
Q4 2019	77.37	43.29	5.22	(1.88)
Q1 2020	76.99	38.60	5.21	(0.78)
Q2 2020	58.24	42.58	5.22	(1.49)
Q3 2020	58.81	38.08	5.21	(2.15)
Q4 2020	76.56	34.70	5.22	(1.76)
Q1 2021	110.33	51.27	5.23	(4.02)
Q2 2021	46.96	71.40	5.26	(0.78)
Q3 2021	78.40	51.48	5.26	(0.32)
Q4 2021	80.01	138.15	5.24	(89.59)
Q1 2022	119.23	83.25	5.23	(34.90)
Q2 2022	101.13	91.90	5.22	(43.36)
Q3 2022	82.07	82.21	5.22	(37.20)
Q4 2022	72.06	66.51	5.21	(26.56)
Q1 2023	77.96	79.18	5.21	(31.29)
Q2 2023	70.49	78.02	1.18	(25.55)
Q3 2023	65.12	47.76	0.03	(23.59)
Q4 2023	68.23	64.25	0.03	(31.77)
Q1 2024	63.49	56.00	0.04	(21.44)
Q2 2024	60.95	56.38	0.02	(28.80)
Q3 2024	66.88	60.01	0.02	(30.50)

Period	Epoxy Resins Products	Chlor Alkali Products	Others	Consolidation adjustments & eliminations
2014	594.51	208.00	-	(127.12)
2015	342.77	163.32	-	(46.42)
2016	280.56	170.13	20.70	(18.53)
2017	354.24	262.07	20.74	(38.38)
2018	394.92	231.08	20.97	(22.62)
2019	301.88	218.09	20.87	(14.91)
2020	270.60	153.96	20.86	(6.18)
2021	315.70	312.30	20.98	(94.71)
2022	374.49	323.86	20.87	(142.01)
2023	281.79	269.21	6.45	(112.20)

Financial Ratios

	Current
Market Cap (M Riyal)	631.51
Enterprise Value (EV) (M)	1,162.89
Shares Outstanding ((M))	23.52
EPS ( Riyal) (TTM)	(3.69)
Book Value (BV) ( Riyal)	8.52
Par Value ( Riyal)	10.00
Adjusted P/E (Last12)	Neg
P/E (TTM)	NEG
Price/book	3.15
Return on Average Assets (%) (TTM)	(8.38 )
Return on Average Equity (%) (TTM)	(35.32 )

Nama Chemicals Co. (NAMA CHEMICALS)

Twitter

Facebook

Linked in

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Nama Chemicals trims losses to SAR 29.3M in 9M 2024; Q3 at SAR 48.1M

View other reports

Financials (M)

Current Quarter Comparison (M)

Financial results (Million)

Financial results (Million)

Profit Performance (Million)

Profit Performance (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million)

Revenue by Business Segment (Latest) 2024 Q3

Financial Ratios

Share Price

Nama Chemicals Co. (NAMA CHEMICALS)

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

×

Nama Chemicals trims losses to SAR 29.3M in 9M 2024; Q3 at SAR 48.1M

View other reports

Financials (M)

Current Quarter Comparison (M)

Financial results (Million)

Financial results (Million)

Profit Performance (Million)

Profit Performance (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million) Q3 2024

Revenue by Business Segment (Latest) 2024 Q3

Financial Ratios

Share Price

Nama Chemicals Co. (NAMA CHEMICALS)

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

Business Segments (Million)